Zantac Linked to Several Types of Cancers
In 2019, Valisure, an online pharmacy company, informed the FDA it discovered that ranitidine creates NDMA, a known carcinogen. Research shows that high doses of NDMA increase the risk of colorectal, bladder, and stomach cancer. NDMA exposure has also been linked to liver fibrosis and scarring; tumors in the lungs, kidneys, and liver; reduced function of the liver, kidneys, and lungs; and symptoms such as jaundice, headaches, abdominal cramps, and dizziness.
NDMA is currently classified as a probable carcinogen that may only cause cancer after longer-term exposure to higher doses, although ranitidine use is not recommended long-term. According to some reports, exposure to Zantac over a period of only a few months may be enough to result in the development of cancer. If you have been exposed to Zantac for a short period of time, you should consult with your doctor and contact an attorney for legal advice and representation.
Cancers and conditions that have been linked to ranitidine include:
- Multiple myeloma
- Non-Hodgkin’s lymphoma
- Small intestine
If you took Zantac and have been diagnosed with any of these cancers or conditions, schedule a free and confidential initial consultation with our experienced legal team at SteinLaw to get the compensation you deserve.
Zantac is facing a class-action lawsuit claiming their drug contains dangerous levels of NDMA and poses a serious cancer risk. Plaintiffs are accusing ranitidine manufacturers of making and marketing a drug they knew or should have known was contaminated with a cancer-causing compound and failed to disclose the risks to the government and consumers.
A growing body of evidence indicates that Boehringer Ingelheim and Sanofi, two major pharmaceutical companies that make Zantac, concealed the cancer link from consumers who took the drug.
Zantac and ranitidine products have now been recalled from the market in the United States. Victims who have suffered harm after taking Zantac may be eligible for compensation for medical bills, pain and suffering, and more. At SteinLaw, we’re accepting clients who have been affected by Zantac.
What Is Zantac?
Zantac is the brand name for ranitidine, an H2 receptor antagonist or H2 blocker used to treat GERD, acid indigestion, and heartburn by reducing the amount of acid the stomach produces.
Ranitidine is the active ingredient in Zantac and it has a molecular structure that can react with itself, producing potentially dangerous levels of the chemical n-nitrosodimethylamine (NDMA) when exposed to high temperatures- including those found inside the human body.
Many major drug stores like CVS pulled generic versions of Zantac and ranitidine from their shelves until further notice and drug manufacturers Apotex and Sandoz recalled their generic versions in the U.S. soon after the discovery. Manufacturers have been asked by the FDA to perform tests and send samples for further examination.
Companies that have already voluntarily recalled ranitidine products include:
- Amneal Pharmaceuticals
- Apotex Corp.
- Lannett Company, Inc
- Novitium Pharma LLC
- Perrigo Company PLC
- Sanofi (manufacturer of brand name Zantac)
If you have been diagnosed with stomach, bladder, or colorectal cancer after taking Zantac, you may be eligible for damages in a class-action lawsuit. Potential damages may include, but are not limited to:
If you took Zantac and developed a serious condition such as cancer, an experienced personal injury lawyer can help you protect your legal rights and explore your options for filing a lawsuit. A Zantac lawyer in Florida with experience with bad drug litigation can help you identify who is liable for your injuries and document the harm you have suffered.
Contact SteinLaw today to speak with a compassionate Zantac attorney who can help you take the next steps and fight for the fair compensation you deserve.